Epigral Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on Jun 28, 2025
EPIGRAL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Epigral Limited has submitted the voting results and scrutinizer's report for its 18th AGM held on June 28, 2025 via video conferencing. All 8 ordinary resolutions were passed with the requisite majority, with over 99.85% approval on each item. Shareholders adopted the FY25 standalone and consolidated financial statements, confirmed an interim dividend of Rs. 2.50 per share and approved a final dividend of Rs. 3.50 per share, taking total dividend for FY25 to Rs. 6 per share. Two directors — Mr. Darshan Patel and Mr. Kaushal Soparkar — were re-appointed, M/s. S R B C & Co LLP was ratified as statutory auditor for FY26, and a change in the nature of directorship of Chairman and MD Mr. Maulik Patel was also approved. Around 67.25–67.28% of total equity shares were voted, with promoter group participation at 87.57% and public institutional participation around 87%.
This is a routine post-AGM regulatory filing with no negative surprises — every resolution passed with overwhelming support, including dividend approval and director re-appointments. Shareholders can expect the final dividend of Rs. 3.50 per share to be paid as per the company's announced record date, while management continuity is maintained with re-appointment of key directors.